Myelogenous Leukemia, Chronic, Chronic Phase
Also known as: Myeloid Leukemia, Chronic, Chronic-Phase / Chronic Phase of Chronic Myeloid Leukemia / Leukemia, Myeloid, Chronic-Phase / Chronic Myeloid Leukemia in Chronic Phase / Leukemia, Myelogenous, Chronic Phase / Chronic Phase Chronic Myelogenous Leukemia / Chronic Myeloid Leukemia, Chronic Phase / Chronic Phase Chronic Myeloid Leukemia / Leukemia, Myeloid, Chronic Phase / Chronic Myelogenous Leukemia - Chronic Phase / Chronic Phase-Chronic Myeloid Leukemia / Chronic Myeloid Leukemia - Chronic Phase / Myeloid Leukemia, Chronic, Chronic Phase / Leukemia, Myeloid, Chronic-Phase (CML-CP) / CML in Chronic Phase / CML, Chronic Phase / Chronic Phase CML / Chronic phase chronic myeloid leukemia (disorder) / Chronic phase chronic myeloid leukaemia / Chronic myeloid leukaemia / Leukemia myelocytic chronic / Leukaemia myelocytic chronic / Chronic granulocytic leukaemia / Chronic myelogenous leukaemia / Myeloid leukemia, chronic / Chronic myelogenous leukemia / Chronic granulocytic leukemia / Myeloid leukaemia, chronic / CML / Chronic myelocytic leukaemia / Chronic myelocytic leukemia / Chronic myeloid leukemia / Leukaemias chronic myeloid / Chronic myeloid leukemia, BCR/ABL-positive / Chronic myeloid leukemia (disorder) / Chronic myeloid leukemia (morphologic abnormality) / Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Drug | Drug Name | Drug Description |
---|---|---|
DB12597 | Asciminib | An inhibitor of ABL/BCR-ABL1 tyrosine kinase for the treatment of patients with Philadelphia chromosome-positive CML, including those with the T315I mutation. |
DB06616 | Bosutinib | An antineoplastic agent used for the treatment of chronic, accelerated, or blast phase Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML) in adults with inadequate clinical response to other treatments. |
DB01254 | Dasatinib | A tyrosine kinase inhibitor used for the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia or chronic myeloid leukemia. |
DB00694 | Daunorubicin | An anthracycline aminoglycoside used to induce remission of nonlymphocytic leukemia and acute lymphocytic leukemia. |
DB04868 | Nilotinib | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. |
DB08901 | Ponatinib | A kinase inhibitor used to treat patients with various types of chronic myeloid leukemia (CML). |